Publicacións en colaboración con investigadores/as de Eli Lilly and Company (14)

2023

  1. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review

    Advances in Therapy, Vol. 40, Núm. 5, pp. 1975-2014

  2. Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study

    Rheumatology and Therapy, Vol. 10, Núm. 5, pp. 1319-1333

  3. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1913-1924

2022

  1. Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis

    Seminars in Arthritis and Rheumatism, Vol. 56

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

2020

  1. Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

    Pain, Vol. 161, Núm. 9, pp. 2068-2078

2017

  1. Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial

    Journal of Bone and Mineral Research, Vol. 32, Núm. 5, pp. 1040-1051

2016

  1. Effects of teriparatide compared with risedronate on recovery after pertrochanteric hip fracture results of a randomized, active-controlled, double-blind clinical trial at 26 weeks

    Journal of Bone and Joint Surgery - American Volume, Vol. 98, Núm. 22, pp. 1868-1878

  2. Effets du tériparatide et du risédronate sur la DMO et la consolidation fracturaire chez des patients âgés avec fracture pertrochantérique récente: Résultats finaux d'un essai clinique randomisé de 78 semaines

    Revue du Rhumatisme (Edition Francaise), Vol. 83, pp. A83-A84

2014

  1. Common variant at 16p11.2 conferring risk of psychosis

    Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114

2002

  1. Características de la versión española del cuestionario de calidad de vida QLSM-H en sujetos adultos con deficiencia de hormona de crecimiento tratados con somatotropina. Estudio piloto

    Endocrinologia y Nutricion, Vol. 49, Núm. 4, pp. 105-112

2001

  1. Fluoxetine in the prevention of depressive recurrences: A double-blind study

    Journal of Clinical Psychopharmacology, Vol. 21, Núm. 4, pp. 417-424

1997

  1. Double blind clinical trial comparing 5 days of dirythromycin versus 7 days of diacetymidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 15, Núm. 7, pp. 357-360